[Corrigendum] Elevated microRNA‑125b levels predict a worse prognosis in HER2‑positive breast cancer patients
Oncology Letters · 29.10.2026 · 32 (6) · 1-2
DOI: 10.3892/ol.2026.15928 ↗Kurz gefasst
Korrektur in der Zeitschrift Oncology Letters, online erschienen am 29.10.2026. Verfasst von Yanwei Luo und 14 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Luo, Y., Wang, X., Niu, W., Wang, H., Wen, Q., Fan, S., Zhao, R., Li, Z., Xiong, W., Peng, S., Zeng, Z., Li, X., Li, G., Tan, M., & Zhou, M. (2026). [Corrigendum] Elevated microRNA‑125b levels predict a worse prognosis in HER2‑positive breast cancer patients. Oncology Letters, 32(6), 1-2. https://doi.org/10.3892/ol.2026.15928
Vancouver
Luo Y, Wang X, Niu W, Wang H, Wen Q, Fan S, et al. [Corrigendum] Elevated microRNA‑125b levels predict a worse prognosis in HER2‑positive breast cancer patients. Oncology Letters. 2026;32(6):1-2. doi:10.3892/ol.2026.15928
BibTeX
@article{Luo2026,
author = {Luo, Yanwei and Wang, Xinye and Niu, Weihong and Wang, Heran and Wen, Qiuyuan and Fan, Songqing and Zhao, Ran and Li, Zheng and Xiong, Wei and Peng, Shuping and Zeng, Zhaoyang and Li, Xiaoling and Li, Guiyuan and Tan, Ming and Zhou, Ming},
title = {[Corrigendum] Elevated microRNA‑125b levels predict a worse prognosis in HER2‑positive breast cancer patients},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {6},
pages = {1--2},
doi = {10.3892/ol.2026.15928}
}
EUVIMED